Clinical Trials Browser

Completed × Non-Squamous Non-Small Cell Lung Cancer × Paclitaxel × Clear all

NCT00974584 2016-11-02

A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Phase 1 Completed

Non-Squamous Non-Small Cell Lung Cancer

NCT01366131 2016-11-02

Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)

Phase 2 Completed

Non-Squamous Non-Small Cell Lung Cancer

NCT01496742 2016-09-23

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer

Phase 2 Completed

Non-Squamous Non-Small Cell Lung Cancer

NCT01519804 2016-09-02

A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer

Phase 2 Completed

Non-Squamous Non-Small Cell Lung Cancer